East Windsor, NJ - The FDA has given i-STAT Corporation clearance to market its prothrombin time (PT) test for use with the company's portable clinical analyzer according to a company press release.

Recently, another modified one-stage method, developed by Owren, 7 has been given the distinctive name of thrombotest. Claims have been made that this test is more satisfactory for controlling ...

THE increasing enthusiasm for treating thromboembolic diseases with prothrombin-reducing drugs for long periods in ambulatory patients has emphasized the lack of clear definition of the therapeutic ...